116 related articles for article (PubMed ID: 8198572)
21. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor.
Hartt JK; Liang T; Sahagun-Ruiz A; Wang JM; Gao JL; Murphy PM
Biochem Biophys Res Commun; 2000 Jun; 272(3):699-704. PubMed ID: 10860818
[TBL] [Abstract][Full Text] [Related]
22. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.
Christophe T; Karlsson A; Rabiet MJ; Boulay F; Dahlgren C
Scand J Immunol; 2002 Nov; 56(5):470-6. PubMed ID: 12410796
[TBL] [Abstract][Full Text] [Related]
23. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
24. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.
Le Y; Gong W; Tiffany HL; Tumanov A; Nedospasov S; Shen W; Dunlop NM; Gao JL; Murphy PM; Oppenheim JJ; Wang JM
J Neurosci; 2001 Jan; 21(2):RC123. PubMed ID: 11160457
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages.
Yang D; Chen Q; Le Y; Wang JM; Oppenheim JJ
J Immunol; 2001 Mar; 166(6):4092-8. PubMed ID: 11238658
[TBL] [Abstract][Full Text] [Related]
26. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.
Devosse T; Guillabert A; D'Haene N; Berton A; De Nadai P; Noel S; Brait M; Franssen JD; Sozzani S; Salmon I; Parmentier M
J Immunol; 2009 Apr; 182(8):4974-84. PubMed ID: 19342677
[TBL] [Abstract][Full Text] [Related]
27. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
Forsman H; Dahlgren C
Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
[TBL] [Abstract][Full Text] [Related]
28. Identification of a gene encoding for the human formyl peptide receptor.
De Nardin E; Radel SJ; Lewis N; Genco RJ; Hammarskjöld M
Biochem Int; 1992 Mar; 26(3):381-7. PubMed ID: 1627151
[TBL] [Abstract][Full Text] [Related]
29. Cellular responses to FMLP challenging: a mini-review.
Panaro MA; Mitolo V
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):397-419. PubMed ID: 10466071
[TBL] [Abstract][Full Text] [Related]
30. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
31. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast.
Klein C; Paul JI; Sauvé K; Schmidt MM; Arcangeli L; Ransom J; Trueheart J; Manfredi JP; Broach JR; Murphy AJ
Nat Biotechnol; 1998 Dec; 16(13):1334-7. PubMed ID: 9853614
[TBL] [Abstract][Full Text] [Related]
32. Expression of functional formyl peptide receptors by human astrocytoma cell lines.
Le Y; Hu J; Gong W; Shen W; Li B; Dunlop NM; Halverson DO; Blair DG; Wang JM
J Neuroimmunol; 2000 Nov; 111(1-2):102-8. PubMed ID: 11063827
[TBL] [Abstract][Full Text] [Related]
33. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
34. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
[TBL] [Abstract][Full Text] [Related]
35. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.
Cui Y; Le Y; Yazawa H; Gong W; Wang JM
J Leukoc Biol; 2002 Oct; 72(4):628-35. PubMed ID: 12377930
[TBL] [Abstract][Full Text] [Related]
36. N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes.
Le Y; Jiang S; Hu J; Gong W; Su S; Dunlop NM; Shen W; Li B; Ming Wang J
Clin Immunol; 2000 Sep; 96(3):236-42. PubMed ID: 10964542
[TBL] [Abstract][Full Text] [Related]
37. Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.
Brandenburg LO; Seyferth S; Wruck CJ; Koch T; Rosenstiel P; Lucius R; Pufe T
Mol Membr Biol; 2009 Aug; 26(5):371-83. PubMed ID: 19707939
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain.
Tiffany HL; Lavigne MC; Cui YH; Wang JM; Leto TL; Gao JL; Murphy PM
J Biol Chem; 2001 Jun; 276(26):23645-52. PubMed ID: 11316806
[TBL] [Abstract][Full Text] [Related]
39. Sequence and organization of the human N-formyl peptide receptor-encoding gene.
Murphy PM; Tiffany HL; McDermott D; Ahuja SK
Gene; 1993 Nov; 133(2):285-90. PubMed ID: 8224916
[TBL] [Abstract][Full Text] [Related]
40. Role(s) of formyl-peptide receptors expressed in nasal epithelial cells.
Prevete N; Salzano FA; Rossi FW; Rivellese F; Dellepiane M; Guastini L; Mora R; Marone G; Salami A; De Paulis A
J Biol Regul Homeost Agents; 2011; 25(4):553-64. PubMed ID: 22217988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
